[常见药物代谢与吉尔伯特综合征中药物使用预防措施之间的相互作用]
D C Dacheng1, C Liang1, S J Zheng1
1The First Department of Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
概括
吉尔伯特综合征是一种常见的遗传性疾病,影响UGT1A1基因活性,影响胆红素水平. 本综述强调了吉尔伯特综合征患者的关键药物相互作用和使用预防措施.
科学领域:
- 遗传学和分子生物学
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 吉尔伯特综合征是一种遗传性疾病,其特征是尿素二酸糖转移酶1A1 (UGT1A1) 活性降低.
- 这导致非结合性胆红素水平升高,尽管通常被认为是良性的,但影响5%-10%的人口.
- 这种情况需要仔细考虑由于UGT1A1功能的改变而导致的药物相互作用.
研究的目的:
- 审查常见药物和吉尔伯特综合征之间的代谢相互作用.
- 为在吉尔伯特综合征患者中提供药物管理的基本预防措施.
- 提高临床管理和患者在药物治疗方面的安全性.
主要方法:
- 关于吉尔伯特综合征和药物代谢研究的文献综述.
- 对UGT1A1活性对药物的疗效和毒性的影响分析.
- 关于在吉尔伯特综合征中使用药物的临床指南和病例报告的汇编.
主要成果:
- 吉尔伯特综合征中UGT1A1活性降低可以改变各种药物的新陈代谢.
- 药物相互作用可能导致胆红素水平降低或增加.
- 药物的新陈代谢发生变化可能会导致效率降低,不良反应或危及生命的情况.
结论:
- 吉尔伯特综合征患者由于UGT1A1活性发生变化,需要个性化药物治疗.
- 医疗保健提供者必须意识到潜在的药物相互作用,并密切监测患者.
- 需要进一步的研究来充分阐明吉尔伯特综合征中药物代谢途径.
相关概念视频
Factors Affecting Drug Biotransformation: Biological
75
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
75
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K
Factors Influencing Drug Absorption: Disease States and Pharmacology
342
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
342
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
115
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
115
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
41
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
41
Drug Metabolism: Phase II Reactions
3.4K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.4K


